Microdosing GLP-1s Is Misleading Clinics

"Microdosing" is doing a lot of work right now in the GLP-1 space. Too much. The way microdosing was originally described for GLP-1s, it means a fifth to a tenth of the standard starting dose. The point is the smallest dose that does the job. What a lot of clinics and compounding pharmacies are selling as GLP-1 microdosing starts at the standard starting dose. Standard titration from there roughly doubles every four weeks over about 16 weeks. So you are not microdosing. You are just starting the same protocol everyone else starts, with a better story attached. This matters because the framing changes what people think they are getting. Microdosing implies you are being conservative, measured, careful about side effects. But if the dose is the standard starting dose, none of that is actually true. And the side effect signals, flat mood, appetite going from reduced to absent, heart rate creeping up, sleep quality dropping, those can show up at any dose if it is too high for that specific person. The standard starting dose is not automatically safe for everyone, and it is not automatically the right starting point. The goal with these molecules, when you use them properly, is appetite control, not appetite suppression. Past a certain point people stop eating enough and they lose muscle with the fat, unless they are deliberately eating enough protein and training for it. That line is different for different people. Someone who is metabolically unwell may actually need a higher dose than someone who is not. The label tells you almost nothing about where that line sits for any individual. Measure before prescribing and during treatment to close that gap. What are you seeing from the compounding pharmacy side of this?